The ability to evade the immune system through specific inhibitory signalling pathways such as T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein-1 pathways (PD-1/PD-L1) is a fatal hallmark of tumours [100,198,199]. The gene discussed is PDCD1; the disease is neoplasm.